BVF Inc’s aTyr Pharma ATYR Stock Holding History

BVF Inc’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-9,623	Closed	-$2.5M	–	31
2015 Q2	$2.5M	Buy	+9,623	New	+$2.99M	0.44%	25

Other funds holding ATYR

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BVF Inc's ATYR Position: Q3 2015 in Review

BVF Inc sold out of aTyr Pharma (ATYR) in Q3 2015, closing a stake of 9,623 shares — an estimated $2.5M sold.

BVF Inc first reported a position in ATYR in Q2 2015 and held it in 1 quarter. The position peaked at $2.5M in Q2 2015. 50 funds tracked by Wall St. Rank hold ATYR as of Q3 2015.

BVF Inc reported no remaining aTyr Pharma position as of Q3 2015 after selling out during the quarter.
BVF Inc sold 9,623 aTyr Pharma shares in Q3 2015, an estimated $2.5M.
BVF Inc first reported a position in aTyr Pharma in Q2 2015 and held it in 1 quarter.
BVF Inc's aTyr Pharma position peaked at $2.5M in Q2 2015.
50 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2015.

Based on BVF Inc's 13F filing for Q3 2015, filed 16 Nov 2015.